Company Overview
Snapshot
Founded in December 2021, Alison.ai operates with 11–50 employees. The company has raised $18.4M across two funding rounds from seven investors. In November 2024, Alison.ai closed a funding round with Almaz Capital as a lead investor.
Business overview
Alison.ai is a creative intelligence platform that empowers teams to ideate, execute, and evaluate advertising creatives with enhanced clarity. The company's core technology, the Creative Genome, is a proprietary system that deconstructs ad creatives into fundamental elements like hooks, pacing, visuals, messaging, and calls to action. This AI-powered platform connects these elements to performance outcomes and patterns over time, facilitating data-backed video concepts and variations. Alison.ai serves various industries, including mobile gaming, retail, gaming/casino, insurance, and FinTech, operating within the Business Software sector, specifically focusing on Sales & Marketing Solutions and Advertising Platforms.
Strategic signal
In October and November 2025, Alison.ai announced the launch of its innovative Creative Genome technology. This development is significant as it introduces a proprietary system designed to break down creative elements and link them to performance outcomes, providing a data-driven approach to ad creative optimization. For investors, this signals a strategic move to solidify Alison.ai's position as a leader in AI-powered creative intelligence, potentially driving greater efficiency and effectiveness for advertisers and enhancing the company's competitive advantage.
Log in to access full profile ›Company Intelligence Q&A
- What is Alison.ai's primary focus?
- Alison.ai focuses on providing an AI-powered creative intelligence platform that helps teams ideate, execute, and evaluate ad creatives with clarity, leveraging its proprietary Creative Genome technology.
- When was Alison.ai founded?
- Alison.ai was founded in December 2021.
- What significant technology did Alison.ai launch in late 2025?
- In October and November 2025, Alison.ai launched its innovative Creative Genome technology, a proprietary system that analyzes creative elements and connects them to performance outcomes.
- Which investors participated in Alison.ai's November 2024 funding round?
- In November 2024, Alison.ai closed a funding round with Almaz Capital as a lead investor, joined by.
- What was a key funding event for Alison.ai in 2023?
- In May 2023, Alison.ai secured a funding round with Andreessen Horowitz as a lead investor.